Switch to:
More From Other Websites
Baxter (BAX) Beats Q4 Earnings Estimates, Sales Up Y/Y - Analyst Blog Jan 29 2015
Will Baxter International (BAX) Disappoint Earnings in Q4? - Analyst Blog Jan 27 2015
NEKTAR THERAPEUTICS Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jan 26 2015
Nektar grabs more Mission Bay space on cusp of growth spurt Jan 20 2015
Nektar Therapeutics (NKTR): New Analyst Report from Zacks Equity Research - Zacks Equity Research... Jan 15 2015
NEKTAR THERAPEUTICS Files SEC form 8-K, Results of Operations and Financial Condition Jan 13 2015
What Investors Are Expecting Ahead Of Multiple Nektar Therapeutics Catalysts Jan 09 2015
Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 33rd Annual J.P. Morgan... Jan 06 2015
Nektar Presents Data on Target-Specific Biomarkers from Circulating Tumor Cell Sub-Study of Phase 3... Dec 11 2014
Nektar Presents Data on Target-Specific Biomarkers from Circulating Tumor Cell Sub-Study of Phase 3... Dec 11 2014
NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD... Dec 11 2014
Nektar/AstraZeneca's Moventig Gets EU Approval for OIC Dec 10 2014
MOVENTIG® Approved In The European Union For Opioid-Induced Constipation Dec 09 2014
MOVENTIG® Approved In The European Union For Opioid-Induced Constipation Dec 09 2014
AstraZeneca, Nektar constipation drug wins European approval Dec 09 2014
AstraZeneca, Nektar constipation drug wins European approval Dec 09 2014
Biotech: When and Where to Sell Dec 03 2014
Baxter Submits Application For US FDA Approval Of BAX 855, Extended Half-Life Recombinant FVIII... Dec 01 2014
Nektar Therapeutics (NKTR): Strong Industry, Solid Earnings Estimate Revisions Dec 01 2014
Will Nektar Therapeutics (NKTR) Continue to Surge Higher? Nov 26 2014
FDA Grants QIDP Designation to Bayer's Amikacin Inhale and Ciprofloxacin Dry Powder for Inhalation Nov 24 2014
Nektar Presents Preclinical Study Findings for Etirinotecan Pegol (NKTR-102) in Combination with a... Nov 20 2014
Nektar Presents Preclinical Study Findings for Etirinotecan Pegol (NKTR-102) in Combination with a... Nov 20 2014
Nektar Therapeutics (NKTR): An Off-the-Radar Potential Winner Nov 17 2014
NEKTAR THERAPEUTICS Financials Nov 14 2014
10-Q for Nektar Therapeutics Nov 10 2014
Nektar beats Street 3Q forecasts Nov 07 2014
Nektar Therapeutics Reports Financial Results for the Third Quarter of 2014 Nov 06 2014
Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After... Oct 30 2014
Nektar says FDA clears constipation drug Movantik Sep 16 2014
BUZZ-Nektar Therapeutics: FDA approves constipation drug Sep 16 2014
FDA approves AstraZeneca, Nektar constipation drug Sep 16 2014
Nektar Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results Feb 26 2014
Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2013 on Wednesday,... Feb 19 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK